# OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer

- Link: https://www.thailand-business-news.com/pr-news/oncusp-therapeutics-appoints-anthony-kim-as-chief-financial-officer
- Published: 2026-05-14T20:00:00+07:00
- Author: PR Newswire

PRINCETON, N.J., May 14, 2026 /PRNewswire/ — OnCusp Therapeutics, Inc., a clinical-
stage biopharmaceutical company developing differentiated oncology therapies designed
to translate cutting-edge innovation into clinically meaningful outcomes for patients,
today announced the appointment of Anthony Kim as Chief Financial Officer. 

Mr. Kim is a seasoned finance executive with more than 25 years of experience spanning
biotechnology leadership and global capital markets. He brings deep expertise in
capital formation, investor relations, and corporate strategy, having worked across
both private and publicly traded life sciences companies as well as leading investment
banks.

"Anthony’s extensive experience at the intersection of biotech and capital markets
makes him an ideal fit for us as we advance our pipeline and prepare for future 
value inflection points. His track record of building strong investor relationships
and executing complex financings will be instrumental to OnCusp’s next phase of 
growth." said Bing Yuan, Chief Executive Officer of OnCusp Therapeutics.

Most recently, Mr. Kim served as Chief Financial Officer Consultant at Orum Therapeutics,
where he advised the CEO and Board on U.S. capital markets strategy, valuation, 
investor engagement, and public market readiness. Prior to that, he was Chief Financial
Officer of Marker Therapeutics, a publicly traded immuno-oncology company, where
he led financial operations, investor relations, and corporate planning. During 
his tenure, he strengthened the company’s capital position, raising more than $130
million in equity financing and securing additional non-dilutive funding.

Earlier in his career, Mr. Kim spent nearly two decades in investment banking at
J.P. Morgan, Jefferies, Nomura, and Scotiabank, where he executed a broad range 
of equity, debt, and strategic transactions totaling more than $30 billion.

In his role as Chief Financial Officer, Mr. Kim will lead OnCusp’s capital markets
strategy, investor relations, financial planning and operation, working closely 
with the executive team and Board of Directors to support the company’s continued
growth and development.

Mr. Kim holds an AB in Economics from the University of Chicago and an MBA from 
the UCLA Anderson School of Management.

CONTACT: [becky@chancebest.com](https://www.thailand-business-news.com/pr-news/becky@chancebest.com)

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [OnCusp Therapeutics Appoints Anthony Kim as Chief Financial Officer ](http://www.prnasia.com/story/archive/4958477_CN58477_0?rand=184833)